- Home
- MDXG vs ENFN Comparison
MDXG vs ENFN Comparison
Compare MDXG & ENFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- ENFN
- Stock Information
- Founded
- MDXG 2006
- ENFN 1998
- Country
- MDXG United States
- ENFN United States
- Employees
- MDXG N/A
- ENFN N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- ENFN Computer Software: Prepackaged Software
- Sector
- MDXG Health Care
- ENFN Technology
- Exchange
- MDXG Nasdaq
- ENFN Nasdaq
- Market Cap
- MDXG 1.3B
- ENFN 1.1B
- IPO Year
- MDXG N/A
- ENFN 2021
- Fundamental
- Price
- MDXG $7.98
- ENFN $11.50
- Analyst Decision
- MDXG Strong Buy
- ENFN Hold
- Analyst Count
- MDXG 5
- ENFN 5
- Target Price
- MDXG $12.00
- ENFN $10.38
- AVG Volume (30 Days)
- MDXG 518.6K
- ENFN 1.0M
- Earning Date
- MDXG 02-26-2025
- ENFN 03-11-2025
- Dividend Yield
- MDXG N/A
- ENFN N/A
- EPS Growth
- MDXG N/A
- ENFN N/A
- EPS
- MDXG 0.52
- ENFN 0.03
- Revenue
- MDXG $342,804,000.00
- ENFN $195,159,000.00
- Revenue This Year
- MDXG $9.56
- ENFN $18.66
- Revenue Next Year
- MDXG $9.19
- ENFN $17.25
- P/E Ratio
- MDXG $15.86
- ENFN $543.67
- Revenue Growth
- MDXG 10.93
- ENFN 15.78
- 52 Week Low
- MDXG $5.47
- ENFN $7.83
- 52 Week High
- MDXG $10.14
- ENFN $11.80
- Technical
- Relative Strength Index (RSI)
- MDXG 35.32
- ENFN 66.62
- Support Level
- MDXG $7.81
- ENFN $10.92
- Resistance Level
- MDXG $8.54
- ENFN $11.80
- Average True Range (ATR)
- MDXG 0.23
- ENFN 0.16
- MACD
- MDXG -0.05
- ENFN -0.00
- Stochastic Oscillator
- MDXG 18.09
- ENFN 65.91
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About ENFN Enfusion Inc.
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.